InvestorsHub Logo
Followers 686
Posts 142386
Boards Moderated 35
Alias Born 03/10/2004

Re: None

Wednesday, 01/03/2024 2:28:16 PM

Wednesday, January 03, 2024 2:28:16 PM

Post# of 648882
Pfizer Inc (PFE) Stock the Worst to Own in January, Historically
By: Schaeffer's Investment Research | January 3, 2024

• PFE had a rocky 2023, and could stumble to start 2024

• Pfizer stock's rally from 10-year lows could be short-lived, if past is precedent

Pfizer Inc (NYSE:PFE) stock moved steadily lower in 2023, closing 11 out of 12 months lower, with March as the only gainer. Though the shares have been on the rise since their Dec. 13 10-year low of $25.76 -- a result of the company's disappointing 2024 forecast -- PFE might not be in the clear just yet.

Per data from Schaeffer's Senior Quantitative Analyst Rocky White, Pfizer stock is at the top of the list of the worst stocks to own in January. In the past 10 years, the equity has finished lower eight times, averaging a 4% loss. A comparable move from its current perch at $29.86 would send PFE back toward its all-time lows. Furthermore, long-term pressure at the 60-day moving average is still in place.



An unwinding of optimism could provide headwinds as well. At the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the security's 10-day call/put volume ratio of 6.22 ranks higher than all other readings from the past year.

Options look like a good way to go when weighing in on Walgreens. Its Schaeffer's Volatility Scorecard (SVS) of 78 out of 100 means the stock usually exceeds volatility expectations.

Read Full Story »»»

DiscoverGold

Information posted to this board is not meant to suggest any specific action, but to point out the technical signs that can help our readers make their own specific decisions. Caveat emptor!
• DiscoverGold

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.